Stavros Manolagas
Concepts (414)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone and Bones | 38 | 2023 | 494 | 6.070 |
Why?
| Osteoblasts | 45 | 2022 | 475 | 5.520 |
Why?
| Osteoclasts | 36 | 2023 | 428 | 3.790 |
Why?
| Estrogens | 20 | 2022 | 223 | 3.660 |
Why?
| Osteoporosis | 17 | 2025 | 162 | 3.400 |
Why?
| Bone Density | 31 | 2025 | 399 | 2.840 |
Why?
| Osteocytes | 20 | 2015 | 226 | 2.750 |
Why?
| Apoptosis | 29 | 2020 | 1119 | 2.540 |
Why?
| Estrogen Receptor alpha | 8 | 2016 | 85 | 2.490 |
Why?
| Aging | 18 | 2021 | 701 | 2.330 |
Why?
| Glucocorticoids | 11 | 2017 | 235 | 2.330 |
Why?
| Oxidative Stress | 15 | 2018 | 807 | 2.000 |
Why?
| Bone Remodeling | 14 | 2020 | 155 | 1.980 |
Why?
| Mice | 76 | 2023 | 5949 | 1.870 |
Why?
| Animals | 92 | 2023 | 13505 | 1.800 |
Why?
| Androgens | 6 | 2017 | 70 | 1.690 |
Why?
| Osteogenesis | 18 | 2023 | 366 | 1.550 |
Why?
| Bone Resorption | 15 | 2020 | 302 | 1.550 |
Why?
| Signal Transduction | 20 | 2020 | 1671 | 1.540 |
Why?
| Wnt Proteins | 10 | 2016 | 100 | 1.480 |
Why?
| Bone Diseases, Metabolic | 5 | 2022 | 78 | 1.420 |
Why?
| Cell Differentiation | 18 | 2020 | 665 | 1.300 |
Why?
| Parathyroid Hormone | 8 | 2010 | 149 | 1.250 |
Why?
| Forkhead Transcription Factors | 8 | 2016 | 116 | 1.220 |
Why?
| Stem Cells | 11 | 2019 | 177 | 1.210 |
Why?
| Prednisolone | 5 | 2011 | 56 | 1.070 |
Why?
| Mice, Inbred C57BL | 29 | 2019 | 1884 | 1.050 |
Why?
| Gonadal Steroid Hormones | 4 | 2016 | 39 | 1.040 |
Why?
| Receptors, Androgen | 4 | 2015 | 46 | 1.000 |
Why?
| RANK Ligand | 17 | 2023 | 187 | 1.000 |
Why?
| Calcification, Physiologic | 3 | 2020 | 42 | 0.880 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 94 | 0.860 |
Why?
| Chemokine CXCL12 | 2 | 2020 | 32 | 0.790 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.790 |
Why?
| beta Catenin | 5 | 2014 | 102 | 0.780 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 7 | 2010 | 82 | 0.760 |
Why?
| Ovariectomy | 7 | 2022 | 113 | 0.760 |
Why?
| Female | 51 | 2025 | 28171 | 0.730 |
Why?
| Periosteum | 2 | 2012 | 26 | 0.700 |
Why?
| Transcription, Genetic | 12 | 2015 | 378 | 0.670 |
Why?
| Hydrogen Peroxide | 5 | 2016 | 120 | 0.660 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 94 | 0.660 |
Why?
| Cell Nucleus | 4 | 2013 | 187 | 0.630 |
Why?
| Gene Deletion | 9 | 2020 | 272 | 0.630 |
Why?
| Reactive Oxygen Species | 9 | 2018 | 421 | 0.610 |
Why?
| Estradiol | 6 | 2013 | 214 | 0.580 |
Why?
| Femur Head Necrosis | 1 | 2017 | 17 | 0.570 |
Why?
| Femur Head | 1 | 2017 | 25 | 0.560 |
Why?
| Osteonecrosis | 1 | 2017 | 35 | 0.560 |
Why?
| Cells, Cultured | 17 | 2020 | 1567 | 0.560 |
Why?
| Femur | 9 | 2016 | 135 | 0.540 |
Why?
| Alendronate | 4 | 2009 | 24 | 0.530 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 19 | 0.530 |
Why?
| Osteoprotegerin | 4 | 2016 | 53 | 0.500 |
Why?
| Male | 31 | 2025 | 26761 | 0.490 |
Why?
| Biochemistry | 1 | 2015 | 6 | 0.490 |
Why?
| Humans | 42 | 2025 | 52483 | 0.470 |
Why?
| Mice, Transgenic | 16 | 2021 | 552 | 0.460 |
Why?
| Enzyme Activation | 9 | 2015 | 270 | 0.450 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 58 | 0.430 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 21 | 0.430 |
Why?
| Mice, Knockout | 13 | 2022 | 879 | 0.420 |
Why?
| Models, Biological | 10 | 2015 | 735 | 0.420 |
Why?
| Fractures, Spontaneous | 1 | 2013 | 15 | 0.420 |
Why?
| Porosity | 4 | 2017 | 31 | 0.410 |
Why?
| Spinal Fractures | 1 | 2013 | 38 | 0.410 |
Why?
| Steroids | 1 | 2013 | 59 | 0.410 |
Why?
| Cell Lineage | 5 | 2016 | 85 | 0.390 |
Why?
| Dexamethasone | 4 | 2011 | 438 | 0.380 |
Why?
| Cell Count | 6 | 2020 | 149 | 0.380 |
Why?
| Transcription Factors | 8 | 2013 | 566 | 0.380 |
Why?
| Immunoglobulin M | 2 | 2025 | 60 | 0.370 |
Why?
| NF-kappa B | 4 | 2017 | 322 | 0.370 |
Why?
| Homeodomain Proteins | 3 | 2022 | 80 | 0.370 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2016 | 399 | 0.360 |
Why?
| Pain | 1 | 2013 | 362 | 0.350 |
Why?
| TCF Transcription Factors | 2 | 2007 | 11 | 0.350 |
Why?
| Phospholipids | 2 | 2021 | 59 | 0.350 |
Why?
| Spine | 6 | 2016 | 89 | 0.350 |
Why?
| Homeostasis | 4 | 2017 | 201 | 0.350 |
Why?
| Cell Line | 11 | 2011 | 1030 | 0.340 |
Why?
| Orchiectomy | 2 | 2015 | 38 | 0.340 |
Why?
| Protein Kinase C | 1 | 2010 | 68 | 0.340 |
Why?
| Disease Models, Animal | 2 | 2016 | 1478 | 0.340 |
Why?
| Muscle, Skeletal | 2 | 2015 | 804 | 0.330 |
Why?
| Membrane Glycoproteins | 4 | 2006 | 244 | 0.330 |
Why?
| Bone Diseases | 2 | 2010 | 96 | 0.330 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.330 |
Why?
| Menopause | 1 | 2010 | 38 | 0.330 |
Why?
| Carrier Proteins | 4 | 2006 | 313 | 0.320 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 72 | 0.320 |
Why?
| Water | 1 | 2009 | 82 | 0.320 |
Why?
| Mitosis | 2 | 2008 | 88 | 0.310 |
Why?
| Mitogen-Activated Protein Kinases | 4 | 2015 | 155 | 0.300 |
Why?
| Calcium | 5 | 2014 | 376 | 0.300 |
Why?
| Organ Size | 4 | 2016 | 228 | 0.300 |
Why?
| Interleukin-6 | 4 | 2016 | 278 | 0.300 |
Why?
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2008 | 11 | 0.300 |
Why?
| Receptors, Estrogen | 2 | 2006 | 131 | 0.290 |
Why?
| Mitochondria | 3 | 2021 | 430 | 0.290 |
Why?
| Bone Density Conservation Agents | 1 | 2009 | 75 | 0.290 |
Why?
| Gene Expression Regulation | 8 | 2020 | 990 | 0.290 |
Why?
| Phosphorylation | 7 | 2010 | 528 | 0.290 |
Why?
| Cholesterol | 1 | 2008 | 153 | 0.280 |
Why?
| Estrenes | 2 | 2006 | 11 | 0.280 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 151 | 0.280 |
Why?
| Glucose | 2 | 2016 | 355 | 0.260 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 29 | 0.260 |
Why?
| Nerve Tissue Proteins | 1 | 2008 | 187 | 0.260 |
Why?
| Blotting, Western | 7 | 2016 | 590 | 0.260 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 72 | 0.250 |
Why?
| Scavenger Receptors, Class B | 2 | 2023 | 10 | 0.250 |
Why?
| X-Ray Microtomography | 5 | 2016 | 79 | 0.240 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 34 | 0.240 |
Why?
| Receptors, Calcitriol | 1 | 2005 | 21 | 0.230 |
Why?
| Bone Development | 3 | 2014 | 66 | 0.230 |
Why?
| Phosphorylcholine | 1 | 2025 | 20 | 0.230 |
Why?
| Calcitriol | 1 | 2005 | 39 | 0.230 |
Why?
| Sirtuin 1 | 2 | 2015 | 29 | 0.230 |
Why?
| src-Family Kinases | 1 | 2005 | 34 | 0.230 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 21 | 0.230 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 58 | 0.230 |
Why?
| RNA | 3 | 2023 | 168 | 0.230 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 582 | 0.220 |
Why?
| Vesicular Transport Proteins | 2 | 2016 | 38 | 0.220 |
Why?
| Pseudohypoparathyroidism | 1 | 2003 | 1 | 0.220 |
Why?
| Cell Proliferation | 5 | 2018 | 1023 | 0.210 |
Why?
| Cell Survival | 7 | 2012 | 612 | 0.200 |
Why?
| Integrases | 4 | 2016 | 44 | 0.200 |
Why?
| Reproducibility of Results | 2 | 2018 | 1229 | 0.200 |
Why?
| Adipogenesis | 2 | 2020 | 49 | 0.200 |
Why?
| Oxidation-Reduction | 5 | 2020 | 326 | 0.200 |
Why?
| Stress, Mechanical | 3 | 2013 | 92 | 0.200 |
Why?
| Osteocalcin | 2 | 2020 | 45 | 0.190 |
Why?
| Adenosine Triphosphate | 2 | 2020 | 205 | 0.190 |
Why?
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 34 | 0.190 |
Why?
| Diphosphonates | 3 | 2008 | 92 | 0.190 |
Why?
| Sirtuin 3 | 1 | 2021 | 18 | 0.180 |
Why?
| Up-Regulation | 3 | 2010 | 454 | 0.180 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 179 | 0.180 |
Why?
| Bone Marrow Cells | 3 | 2015 | 190 | 0.170 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.170 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 422 | 0.170 |
Why?
| RNA, Messenger | 7 | 2010 | 1132 | 0.170 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 22 | 0.170 |
Why?
| Oxidative Phosphorylation | 1 | 2020 | 46 | 0.170 |
Why?
| Cell Division | 2 | 2015 | 291 | 0.170 |
Why?
| Atherosclerosis | 2 | 2016 | 219 | 0.160 |
Why?
| Transfection | 6 | 2007 | 357 | 0.160 |
Why?
| Connexin 43 | 4 | 2008 | 25 | 0.150 |
Why?
| MAP Kinase Kinase 4 | 2 | 2011 | 29 | 0.150 |
Why?
| Bone Morphogenetic Proteins | 2 | 2010 | 58 | 0.150 |
Why?
| Ligands | 5 | 2007 | 206 | 0.150 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2010 | 45 | 0.150 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 169 | 0.150 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 21 | 0.150 |
Why?
| Epitopes | 1 | 2018 | 65 | 0.140 |
Why?
| Phenotype | 4 | 2015 | 789 | 0.140 |
Why?
| Biological Evolution | 1 | 2018 | 52 | 0.140 |
Why?
| Lipid Metabolism | 2 | 2009 | 187 | 0.140 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 202 | 0.130 |
Why?
| Myeloid Cells | 1 | 2016 | 39 | 0.130 |
Why?
| Glycoproteins | 2 | 2010 | 122 | 0.130 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 36 | 0.130 |
Why?
| HeLa Cells | 4 | 2005 | 265 | 0.130 |
Why?
| Lysosomes | 1 | 2016 | 76 | 0.130 |
Why?
| Quantitative Trait Loci | 2 | 2006 | 50 | 0.130 |
Why?
| Autophagy | 2 | 2015 | 193 | 0.130 |
Why?
| Protein Structure, Tertiary | 3 | 2007 | 242 | 0.120 |
Why?
| Gene Expression | 4 | 2023 | 618 | 0.120 |
Why?
| Apolipoproteins E | 1 | 2016 | 55 | 0.120 |
Why?
| Body Weight | 2 | 2010 | 523 | 0.120 |
Why?
| Time Factors | 6 | 2008 | 2968 | 0.120 |
Why?
| History, 21st Century | 1 | 2015 | 59 | 0.120 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 137 | 0.120 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 3 | 2004 | 50 | 0.120 |
Why?
| Absorptiometry, Photon | 4 | 2016 | 162 | 0.120 |
Why?
| History, 20th Century | 1 | 2015 | 96 | 0.120 |
Why?
| Microtubule-Associated Proteins | 2 | 2013 | 65 | 0.120 |
Why?
| Aorta | 1 | 2016 | 165 | 0.120 |
Why?
| National Institutes of Health (U.S.) | 1 | 2014 | 43 | 0.110 |
Why?
| Sarcopenia | 1 | 2015 | 98 | 0.110 |
Why?
| Calcium, Dietary | 1 | 2014 | 14 | 0.110 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 104 | 0.110 |
Why?
| Catalase | 1 | 2014 | 73 | 0.110 |
Why?
| FMN Reductase | 1 | 2013 | 3 | 0.110 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2016 | 221 | 0.110 |
Why?
| Cytoplasm | 2 | 2004 | 94 | 0.110 |
Why?
| Plasmids | 2 | 2004 | 163 | 0.110 |
Why?
| Fracture Healing | 1 | 2013 | 27 | 0.100 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 33 | 0.100 |
Why?
| Atrophy | 1 | 2013 | 45 | 0.100 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 70 | 0.100 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 169 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 2 | 2009 | 1378 | 0.100 |
Why?
| Bone Marrow | 2 | 2013 | 364 | 0.100 |
Why?
| Iron | 1 | 2013 | 127 | 0.100 |
Why?
| Uterus | 1 | 2013 | 88 | 0.100 |
Why?
| Organ Specificity | 2 | 2010 | 115 | 0.100 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.100 |
Why?
| Research Design | 1 | 2014 | 359 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 67 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Dyneins | 1 | 2011 | 5 | 0.090 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 7 | 0.090 |
Why?
| Bone Matrix | 1 | 2011 | 16 | 0.090 |
Why?
| Lactation | 1 | 2011 | 60 | 0.090 |
Why?
| Macrophages | 2 | 2016 | 379 | 0.090 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 20 | 0.090 |
Why?
| PPAR gamma | 2 | 2009 | 72 | 0.090 |
Why?
| B-Lymphocytes | 1 | 2012 | 184 | 0.090 |
Why?
| Membrane Proteins | 1 | 2013 | 335 | 0.090 |
Why?
| Linear Models | 2 | 2009 | 287 | 0.090 |
Why?
| Oxidants | 1 | 2010 | 51 | 0.090 |
Why?
| Solubility | 1 | 2010 | 79 | 0.090 |
Why?
| Genes, Reporter | 2 | 2017 | 88 | 0.090 |
Why?
| Genetic Markers | 1 | 2010 | 109 | 0.090 |
Why?
| Smad1 Protein | 1 | 2010 | 5 | 0.090 |
Why?
| Glutathione Reductase | 1 | 2010 | 14 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 105 | 0.080 |
Why?
| Turner Syndrome | 1 | 2010 | 15 | 0.080 |
Why?
| Chimera | 1 | 2010 | 10 | 0.080 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 93 | 0.080 |
Why?
| Transgenes | 1 | 2010 | 51 | 0.080 |
Why?
| Gene Targeting | 1 | 2010 | 31 | 0.080 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 59 | 0.080 |
Why?
| Cell Death | 1 | 2010 | 177 | 0.080 |
Why?
| Acid Phosphatase | 1 | 2009 | 12 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 182 | 0.080 |
Why?
| Thymidine Kinase | 1 | 2008 | 19 | 0.080 |
Why?
| Ganciclovir | 1 | 2008 | 24 | 0.080 |
Why?
| Skull | 2 | 2009 | 80 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 9 | 0.080 |
Why?
| Cell Membrane | 2 | 2007 | 245 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 166 | 0.070 |
Why?
| Postmenopause | 1 | 2009 | 82 | 0.070 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 25 | 0.070 |
Why?
| Multienzyme Complexes | 2 | 2009 | 40 | 0.070 |
Why?
| Collagen Type I | 1 | 2008 | 83 | 0.070 |
Why?
| Blotting, Northern | 2 | 2005 | 106 | 0.070 |
Why?
| Multipotent Stem Cells | 1 | 2007 | 3 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 95 | 0.070 |
Why?
| Estrogen Antagonists | 2 | 2007 | 21 | 0.070 |
Why?
| Hormones | 1 | 2007 | 59 | 0.070 |
Why?
| Focal Adhesion Kinase 1 | 1 | 2007 | 14 | 0.070 |
Why?
| DNA Replication | 1 | 2008 | 160 | 0.070 |
Why?
| Anoikis | 1 | 2007 | 8 | 0.070 |
Why?
| Molecular Structure | 2 | 2006 | 314 | 0.070 |
Why?
| Focal Adhesion Kinase 2 | 1 | 2007 | 15 | 0.070 |
Why?
| Extracellular Matrix | 1 | 2007 | 112 | 0.070 |
Why?
| Dihydrotestosterone | 1 | 2006 | 14 | 0.070 |
Why?
| Estrogen Receptor beta | 1 | 2007 | 54 | 0.070 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.070 |
Why?
| Smad Proteins | 1 | 2006 | 12 | 0.070 |
Why?
| Double-Blind Method | 1 | 2009 | 713 | 0.070 |
Why?
| Mechanotransduction, Cellular | 1 | 2007 | 42 | 0.070 |
Why?
| Response Elements | 1 | 2006 | 29 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2007 | 121 | 0.070 |
Why?
| Teriparatide | 1 | 2006 | 10 | 0.070 |
Why?
| Biopsy | 1 | 2009 | 605 | 0.070 |
Why?
| Proto-Oncogene Proteins | 2 | 2005 | 151 | 0.060 |
Why?
| Weightlessness | 1 | 2006 | 13 | 0.060 |
Why?
| Kinetics | 2 | 2004 | 626 | 0.060 |
Why?
| Extracellular Matrix Proteins | 3 | 2014 | 69 | 0.060 |
Why?
| Transforming Growth Factor beta | 1 | 2006 | 138 | 0.060 |
Why?
| Synteny | 1 | 2005 | 7 | 0.060 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 169 | 0.060 |
Why?
| Chromosomes, Human, X | 1 | 2005 | 18 | 0.060 |
Why?
| Histocytochemistry | 1 | 2005 | 45 | 0.060 |
Why?
| Protein Binding | 4 | 2011 | 667 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 256 | 0.060 |
Why?
| Chromosome Mapping | 1 | 2005 | 154 | 0.060 |
Why?
| Endosomes | 2 | 2016 | 36 | 0.060 |
Why?
| Adipocytes | 2 | 2004 | 132 | 0.060 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.060 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2025 | 25 | 0.060 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 34 | 0.060 |
Why?
| Diet, High-Fat | 2 | 2018 | 236 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 50 | 0.060 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 39 | 0.060 |
Why?
| Etoposide | 1 | 2004 | 74 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 83 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 12 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 13 | 0.050 |
Why?
| DNA Primers | 2 | 2014 | 208 | 0.050 |
Why?
| Rats | 2 | 2008 | 3220 | 0.050 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 4 | 0.050 |
Why?
| Co-Repressor Proteins | 1 | 2023 | 18 | 0.050 |
Why?
| United States | 1 | 2014 | 5192 | 0.050 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 5 | 0.050 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Diabetes Mellitus | 1 | 2007 | 316 | 0.050 |
Why?
| Phosphotransferases | 1 | 2003 | 17 | 0.050 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 13 | 0.050 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 13 | 0.050 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 60 | 0.050 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 23 | 0.050 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 75 | 0.050 |
Why?
| Middle Aged | 3 | 2025 | 13028 | 0.050 |
Why?
| Mice, 129 Strain | 2 | 2013 | 37 | 0.050 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 47 | 0.050 |
Why?
| Mutation | 2 | 2007 | 1347 | 0.050 |
Why?
| Immunoblotting | 2 | 2015 | 116 | 0.050 |
Why?
| Receptors, Scavenger | 1 | 2022 | 29 | 0.050 |
Why?
| Down-Regulation | 1 | 2003 | 346 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 1132 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 554 | 0.050 |
Why?
| DNA | 1 | 2005 | 549 | 0.050 |
Why?
| Genitalia | 1 | 2001 | 10 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2017 | 54 | 0.050 |
Why?
| Radiography | 2 | 2013 | 470 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2003 | 334 | 0.040 |
Why?
| Cardiovascular System | 1 | 2001 | 53 | 0.040 |
Why?
| Central Nervous System | 1 | 2001 | 76 | 0.040 |
Why?
| Adult | 2 | 2009 | 14161 | 0.040 |
Why?
| Alleles | 2 | 2012 | 276 | 0.040 |
Why?
| Antibodies, Neutralizing | 1 | 2020 | 78 | 0.040 |
Why?
| Base Sequence | 2 | 2014 | 640 | 0.040 |
Why?
| Sex Characteristics | 1 | 2001 | 198 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2025 | 1678 | 0.040 |
Why?
| Cattle | 2 | 2009 | 205 | 0.040 |
Why?
| GATA4 Transcription Factor | 1 | 2017 | 11 | 0.030 |
Why?
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.030 |
Why?
| Primary Cell Culture | 1 | 2017 | 62 | 0.030 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 68 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 312 | 0.030 |
Why?
| Aniline Compounds | 1 | 2017 | 46 | 0.030 |
Why?
| Models, Animal | 1 | 2017 | 234 | 0.030 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 7 | 0.030 |
Why?
| Genotype | 2 | 2008 | 566 | 0.030 |
Why?
| Sulfonamides | 1 | 2017 | 133 | 0.030 |
Why?
| Embryo, Mammalian | 2 | 2009 | 67 | 0.030 |
Why?
| Species Specificity | 2 | 2006 | 192 | 0.030 |
Why?
| Heme Oxygenase-1 | 1 | 2015 | 18 | 0.030 |
Why?
| Acetylation | 1 | 2015 | 95 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 130 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 86 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2017 | 221 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 305 | 0.030 |
Why?
| Recombination, Genetic | 1 | 2015 | 109 | 0.030 |
Why?
| Histones | 1 | 2017 | 314 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 28 | 0.030 |
Why?
| Fibroblasts | 2 | 2009 | 355 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 185 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 46 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 478 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2006 | 505 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 108 | 0.030 |
Why?
| Fatty Acids | 2 | 2004 | 149 | 0.030 |
Why?
| Cathepsin K | 1 | 2011 | 6 | 0.020 |
Why?
| Histological Techniques | 1 | 2011 | 9 | 0.020 |
Why?
| Adiposity | 1 | 2013 | 143 | 0.020 |
Why?
| Chondrocytes | 1 | 2011 | 41 | 0.020 |
Why?
| Inflammation | 1 | 2016 | 641 | 0.020 |
Why?
| Aged | 1 | 2025 | 10121 | 0.020 |
Why?
| Oxandrolone | 1 | 2010 | 10 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 461 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2012 | 340 | 0.020 |
Why?
| Cartilage | 1 | 2010 | 47 | 0.020 |
Why?
| Body Height | 1 | 2010 | 66 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 4 | 0.020 |
Why?
| Aldehydes | 1 | 2009 | 81 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 79 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 90 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 213 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 118 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 20 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 119 | 0.020 |
Why?
| Caveolin 1 | 1 | 2007 | 22 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 240 | 0.020 |
Why?
| Transcription Initiation Site | 1 | 2006 | 14 | 0.020 |
Why?
| Base Pairing | 1 | 2006 | 27 | 0.020 |
Why?
| Conserved Sequence | 1 | 2006 | 53 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 467 | 0.020 |
Why?
| Cyclic AMP | 1 | 2006 | 91 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 95 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 7 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 10 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 15 | 0.020 |
Why?
| Cycloheximide | 1 | 2005 | 35 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 12 | 0.020 |
Why?
| Crosses, Genetic | 1 | 2005 | 34 | 0.020 |
Why?
| Caspases | 1 | 2006 | 104 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 98 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 377 | 0.020 |
Why?
| Haplotypes | 1 | 2005 | 92 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2006 | 778 | 0.010 |
Why?
| Densitometry | 1 | 2004 | 13 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.010 |
Why?
| Mesoderm | 1 | 2004 | 27 | 0.010 |
Why?
| Drug Synergism | 1 | 2004 | 150 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 727 | 0.010 |
Why?
| Free Radical Scavengers | 1 | 2004 | 25 | 0.010 |
Why?
| Tensile Strength | 1 | 2003 | 31 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 47 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 528 | 0.010 |
Why?
| Acetylcysteine | 1 | 2004 | 102 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 372 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 169 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 117 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 211 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.010 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 39 | 0.010 |
Why?
| Transcription Factor AP-1 | 1 | 2002 | 61 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 42 | 0.010 |
Why?
| src Homology Domains | 1 | 2001 | 7 | 0.010 |
Why?
| Chick Embryo | 1 | 2001 | 81 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2002 | 122 | 0.010 |
Why?
| Adolescent | 1 | 2010 | 6739 | 0.010 |
Why?
| Child | 1 | 2010 | 7248 | 0.010 |
Why?
|
|
Manolagas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|